Chemically induced morphological and neoplastic transformation in C3H/10T1/2 Cl 8 mouse embryo cells

Molecular Carcinogenesis and the Molecular Biology of Human Cancer

Volumn , Issue , 2005, Pages 199-220

  Landolph, Joseph R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 53549092312     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (75)

1. Heidelberger, C. Oncogenic transformation of rodent cell lines by chemical carcinogens. In Origins of Human Cancer, Part C, Human Risk Assessment, Hiatt, J.H., Watson, J.D., and Winsten, J.A., Eds., Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1977, pp. 1513-1520.
2. Heidelberger, C. and Mondal, S. In vitro chemical carcinogenesis. In Carcinogens Identification and Mechanisms of Action, Griffin, A.C. and Shaw, C.R., Eds., New York, Raven Press, 1979, pp. 83-92.
3. Heidelberger, C. Initiation, promotion, transformation, and mutagenesis of mouse embryo cell lines. In Proceedings of the 13th International Cancer Congress, Part B, Biology of Cancer, Mirand, E.A., Hutchinson, W.B., and Mihich, E., Eds., New York, Alan R. Liss, 1983, pp. 83-89.
4. Heidelberger, C., Freeman, A.E., Pienta, R.J., Sivak, A., Bertram, J.S., Casto, B.C., Dunkel, V.C., Francis, M.W., Kakunaga, T., Little, J.B., and Schechtman, L.M. Cell transformation by chemical agents — review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 114: 283-385, 1983.
5. Heidelberger, C., Landolph, J.R., Fournier, R.E.K., Fernandez, A., and Peterson, A.R. Genetic and probability aspects of cell transformation by chemical carcinogens. Prog. Nucleic Acid Res. Mol. Biol., 2: 87-98, 1983.
6. Landolph, J.R. Chemical transformation in C3H/10T1/2 Cl 8 mouse embryo fibroblasts: Historical background, assessment of the transformation assay, and evolution and optimization of the transformation assay protocol. In Transformation Assay of Established Cell Lines: Mechanisms and Applications, Kakunaga, T. and Yamasaki, H., Eds., IARC Scientific Publications, No. 67, International Agency for Research on Cancer, Lyon, France, 1985, pp. 185-198.
7. Reznikoff, C.A., Brankow, D.W., and Heidelberger, C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res., 33: 3231-3238, 1973.
8. Reznikoff, C.A., Bertram, J.S., Brankow, D.W., and Heidelberger, C. Qualitative and quantitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res., 33: 3239-3249, 1973.
9. Ruley, H.E. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature, 304: 601-607, 1983.
10. Landolph, J.R. and Jones, P.A. Mutagenicity of 5-azacytidine and related nucleosides in C3H/10T1/2 Clone 8 and V79 cells. Cancer Res., 42: 817-823, 1982.
11. Constantinides, P.G., Jones, P.A., and Gevers, W. Functional striated muscle cells form non-myoblast precursors following 5-azacytidine treatment. Nature, 267: 364-366, 1977.
12. Constantinides, P.G., Taylor, S.M., and Jones, P.A. Phenotypic conversion of cultured mouse embryo cells by Aza pyrimidine nucleosides. Dev. Biol., 66: 57-71, 1978.
13. Taylor, S.M. and Jones, P.A. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell, 17: 771-779, 1990.
14. Jones, P.A. and Taylor, S.M. Cellular differentiation, cytidine analogs, and DNA methylation. Cell, 20: 85-93, 1980.
15. Landolph, J.R. and Heidelberger, C. Chemical carcinogens produce mutations to ouabain resistance in transformable C3H/10T1/2 Cl 8 mouse fibroblasts. Proc. Natl. Acad. Sci. USA, 76: 930-934, 1979.
16. Gehly, E.B., Landolph, J.R., Heidelberger, C., Nagasawa, H., and Little, J.B. Induction of cytotoxicity, mutation, cytogenetic changes, and neoplastic transformation by benzo(a)pyrene and derivatives in C3H/10T1/2 Clone 8 mouse fibroblasts. Cancer Res., 42: 1866-1875, 1982.
17. 1)Cl-3 cells by cancer chemotherapeutic agents. Cancer Res., 37: 2202-2208, 1977.
18. Billings, P.C., Uwaifo, A., and Heidelberger, C. Influence of benzoflavone on aflatoxin B1-induced cytotoxicity, mutation and transformation of C3H/10T1/2 cells. Cancer Res., 43: 2659-2663, 1983.
19. Billings, P.C, Heidelberger, C., and Landolph, J.R. S-9 metabolic activation enhances aflatoxinmediated transformation of C3H/10T1/2 cells. Toxicol. Appl. Pharmacol., 77: 58-65, 1985.
20. Benedict, W.F., Rucker, N., Faust, J., and Kouri, R.E. Malignant transformation of mouse cells by cigarette smoke condensate. Cancer Res., 35: 857-860, 1975.
21. Patierno, S.R., Bahn, D., and Landolph, J.R. Transformation of C3H/10T1/2 mouse embryo cells to focus formation and anchorage independence by insoluble lead chromate but not by soluble calcium chromate: Relationship to mutagenesis and internalization of lead chromate particles. Cancer Res., 48: 5280-5288, 1988.
22. Miura, T., Patierno, S.R., Sakuramoto, T., and Landolph, J.R. Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds. Environ. Mol. Mutagen., 14: 65-78, 1989.
23. Nianjun, H., Cerapnalkoski, L., Nwankwo, J.O., Dews, M., and Landolph, J.R. Induction of chromosomal aberrations, cytotoxicity, and morphological transformation in mammalian cells by the antiparasitic drug, flubendazole, and the antineoplastic drug, harringtonine. Fundam. Appl. Toxicol., 22: 304-313, 1994.
24. Bertram, J.S. and Heidelberger, C. Cell cycle dependency of oncogenic transformation induced by N-methyl-N-nitro-N-nitrosoguanidine in culture. Cancer Res., 34: 526-537, 1974.
25. Grisham, J.W., Greenburg, D.S., Kaufman, D.G., and Smith, G. Cell cycle related toxicity and transformation in 10T1/2 cells treated with N-methyl-N-nitro-N-nitrosoguanidine. Proc. Natl. Acad. Sci. USA, 77: 4813-4817, 1980.
26. McCormick, P. and Bertram, J.S. Differential cell cycle phase specificity for neoplastic transformation and mutation to ouabain resistance induced by N-methyl-N-nitro-N-nitrosoguanidine. Proc. Natl. Acad. Sci. USA, 79: 4342-4346, 1982.
27. Jones, P.A., Benedict, W.F., Baker, M.S., Mondal, S., Rapp, U., and Heidelberger, C. Oncogenic transformation of C3H/10T1/2 Clone 8 mouse embryo cells by halogenated pyrimidine nucleosides. Cancer Res, 36: 101-107, 1976.
28. Jones, P.A., Baker, M.S., Bertram, J.S., and Benedict, W.F. Cell-cycle specific oncogenic transformation of C3H/10T1/2 Clone 8 mouse embryo cells by 1-ß-D-arabinofuranosylcytosine. Cancer Res., 37: 2214-2217, 1977.
29. Nesnow, S., Garland, H., and Curtis, G. Improved transformation of C3H/10T1/2 Cl cells by direct and indirect-acting carcinogens. Carcinogenesis, 3: 377-380, 1982.
30. Kennedy, A.R., Mondal, S., Heidelberger, C., and Little, J.B. Enhancement of x-ray transformation by 12-0-tetradecanoyl-phorbol-13 acetate in a cloned line of C3H mouse embryo cells. Cancer Res., 38: 439-443, 1978.
31. Kennedy, A.R., Fox, M., Murphy, G., and Little, J.B. Relationship between x-ray exposure and malignant transformation in C3H/10T1/2 cells. Proc. Natl. Acad. Sci. USA, 77: 7262-7266, 1980.
32. Chan, G.L. and Little, G.B. Induction of ouabain resistance mutations in C3H/10T1/2 mouse cells by ultraviolet light. Proc. Natl. Acad. Sci. USA, 75: 3363-3366, 1978.
33. Gehly, E.B., Fahl, W.F., Jefcoate, C.R., and Heidelberger, C. The metabolism of benzo(a)pyrene by cytochrome P-450 in transformable and nontransformable C3H mouse fibroblasts. J. Biol. Chem, 254: 5041-5048, 1979.
34. Gehly, E.B. and Heidelberger, C. Metabolic activation of benzo(a)pyrene by transformable and nontransformable C3H mouse fibroblasts in culture. Cancer Res., 42: 2697-2704, 1982.
35. Wang, T.V. and Cerruti, P.A. Effect of formation and removal of aflatoxin B1: DNA adducts in 10T1/2 mouse embryo fibroblasts on cell viability. Cancer Res., 40: 2904-2909, 1980.
36. Oshiro, Y. and Balweirz, P.S. Morphological transformation of C3H/10T1/2 cells by procarcinogens. Environ. Mutagen., 4: 105-108, 1982.
37. Boreiko, C. and Heidelberger, C. Isolation of mutants temperature-sensitive for expression of the transformed state from chemically transformed C3H/10T1/2 cells. Carcinogenesis, 1: 1059-1073, 1980.
38. Oshiro, Y., Balwierz, P.S., and Piper, C.E. Selection of fetal bovine serum for use in the C3H/10T1/2 Cl 8 cell transformation assay system. Environ. Mutagen., 4: 569-574, 1982.
39. Land, H., Parada, L.F., and Weinberg, R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least the cooperating oncogenes. Nature, 304: 596-602, 1983.
40. Newbold, R.F. and Overell, R.W. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature, 304: 648-651, 1983.
41. Shih, C., Shilo, B., Goldfarb, M.P., Dannenberg, A., and Weinberg, R.A. Passage of the phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc. Natl. Acad. Sci. USA, 76: 5714-5718, 1979.
42. Schechtman, L.M., Kiss, F., McCarvill, J., Gallagher, M., Kouri, R.E., and Lubet, R.A. A method for amplification of sensitivity of the C3H/10T1/2 cell transformation assay. Proc. Am. Assoc. Cancer Res, 23: 74, 1982.
43. Haber, D.A., Fox, D.A., Dynan, W.S., and Thilly, W.G. Cell density dependence of focus formation in the C3H/10T1/2 transformation. Cancer Res., 37: 1644-1648, 1977.
44. Fernandez, A., Mondal, S., and Heidelberger, C. Probabilistic view of the transformation of cultured C3H/10T1/2 mouse embryo fibroblasts by 3-methylcholanthrene. Proc. Natl. Acad. Sci. USA, 77: 7272-7276, 1980.
45. Nelson, R.L. and Garry, V.F. Colony transformation in C3H/10T1/2 cells: Stepwise development of neoplastic change in vitro. In Vitro, 19: 551-558, 1983.
46. Sivak, A. and Tu, A.S. Use of rodent hepatocytes for metabolic activation in transformation assays. In Transformation Assay of Established Cell Lines: Mechanisms and Application, Kakunaga, T. and Yamasaki, H., Eds., IARC Scientific Publications No. 67., International Agency for Research on Cancer, Lyon, France, 1985, pp. 121-136.
47. Schechtman, L.M. Metabolic activation of procarcinogens by subcellular enzyme fractions in the C3H/10T1/2 and Balb/c3T3 cell transformation systems. In Transformation Assay of Established Cell Lines: Mechanisms and Application, Kakunaga, T. and Yamasaki, H., Eds., IARC Scientific Publications No. 67, International Agency for Research on Cancer, Lyon, France, 1985, pp. 137-162.
48. Tu, A., Breen, P., Pallotta, S., and Sivak, A. Examination of modified procedures for the C3H/10T1/2 neoplastic transformation assay. Proc. Am. Assoc. Cancer Res., 24: 103, 1983.
49. Landolph, J.R., Telfer, N., and Heidelberger, C. Further evidence that ouabain-resistant variants induced by chemical carcinogens in transformable C3H/10T1/2 Cl 8 mouse fibroblasts are mutants. Mutat. Res, 72: 295-310, 1980.
50. Shibuya, M.L., Miura, T., Lillehaug, J.R., Farley, R.A., and Landolph, J.R. Ouabain-resistant (Na, K)-ATPase enzyme activity in chemically induced ouabain-resistant C3H/10T1/2 cells. J. Mol. Toxicol., 2: 75-98, 1989.
51. 86rubidium transport in wild-type and ouabain-resistant C3H/10T1/2 mouse fibroblasts. Cancer Res., 40: 4581-4588, 1980.
52. Landolph, J.R. and Fournier, R.E.K. Microcell-mediated transfer of carcinogen-induced ouabain resistance from C3H/10T1/2 Cl 8 mouse fibroblasts to human cells. Mutat. Res., 107: 447-463, 1983.
53. Landolph, J.R. Neoplastic transformation of mammalian cells by carcinogenic metal compounds: Cellular and molecular mechanisms. In Biological Effects of Heavy Metals, Volume II: Metal Carcinogenesis, Foulkes, E.C., Ed., CRC Press, Boca Raton, FL, 1990, pp. 2-18, chap. 1.
54. Peterson, A.R., Landolph, J.R., Peterson, H., Spears, C.P., and Heidelberger, C. Oncogenic transformation and mutation of C3H/10T1/2 Clone 8 mouse embryo fibroblasts by alkylating agents. Cancer Res., 41: 3095-3099, 1981.
55. Saxholm, H.J.K., Reith, A., and Brogger, A. Oncogenic transformation and cell lysis in C3H/10T1/2 cells and increased sister chromatid exchange in human lymphocytes by nickel subsulfide. Cancer Res., 41: 4136-4139, 1981.
56. Landolph, J.R. Molecular mechanisms of transformation of C3H/10T1/2 Cl 8 mouse embyro cells and diploid human fibroblasts by carcinogenic metal compounds. Environ. Health Perspect., 102 (Suppl. 3): 119-125, 1994.
57. Merriman, R.L. and Bertram, J.S. Reversible inhibition by retinoids of 3-methylcholanthrene-induced neoplastic transformation in C3H/10T1/2 Cl 8 cells. Cancer Res., 39: 1661-1666, 1979.
58. Mordan, L.J., Bersin, L.M., Budnick, J.L., Meegan, R.R., and Bertram, J.S. Isolation of methylcholanthrene-‘initiated’ C3H/10T1/2 cells by inhibiting neoplastic progression with retinyl acetate. Carcinogenesis, 3: 249-285, 1982.
59. Benedict, W.F., Wheatley, W.I., and Jones, P.A. Inhibition of chemically induced morphological transformation and reversion of the transformed phenotype by ascorbic acid in C3H/10T1/2 cells. Cancer Res, 40: 2796-2801, 1980.
60. Mondal, S., Brankow, D.M., and Heidelberger, C. Two-stage chemical carcinogenesis in cultures of C3H/10T1/2 cells. Cancer Res, 36: 2254-2260, 1976.
61. Boreiko, C.J., Rajan, D.L., Abernethy, D.J., and Frazelle, J.H. Initiation of C3H/10T1/2 cell transformation by N-methyl-N-nitro-N-nitrosoguanidine and aflatoxin B1. Carcinogenesis, 3: 391-395, 1982.
62. Shuin, T., Billings, P.C., Lillehaug, J.R., Patierno, S.R., Roy-Burman, P., and Landolph, J.R. Enhanced expression of c-myc and decreased expression of c-fos proto-oncogenes in chemically and radiation-transformed C3H/10T1/2 mouse embryo cell lines. Cancer Res., 46: 5302-5311, 1986.
63. Billings, P.C., Shuin, T., Lillehaug, J., Miura, T, Roy-Burman, P., and Landolph, J.R. Enhanced expression and state of the c-myc oncogene in chemically and x-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts. Cancer Res., 47: 3643-3649, 1987.
64. Clemens, F. and Landolph, J.R. Genotoxicity of samples of nickel refinery dust. Toxicol. Sci, 73: 114-123, 2003.
65. Landolph, J.R., Verma, A., Ramnath, J., and Clemens, F. Molecular biology of deregulated gene expression in transformed C3H/10T1/2 mouse embryo cell lines induced by specific insoluble carcinogenic nickel compounds. Environ. Health Perspect., 110 (Suppl. 5): 845-850, 2002.
66. Verma, R., Ramnath, J., Clemens, F., Kaspin, L.C., and Landolph, J.R. Molecular biology of nickel carcinogenesis: Identification of differentially expressed genes in morphologically transformed C3H/10T1/2 Cl 8 mouse embryo fibroblast cell lines induced by specific insoluble nickel compounds. Mol. Cell. Biochem, 255: 203-216, 2004.
67. Ora, A. and Henenius, A. Calnexin fails to associate with substrate proteins in gluconidase-deficient cell lines. J. Biol. Chem, 270: 26060-26062, 1995.
68. Galvin, K., Krishna, S., Pnochel, F., Frolich, M., Cummings, D.E., Carlson, R., Wands, J.R., Isselbacher, J.K., Pillai, S., andOzturk, M. The major histocompatibility complex class I antigen-biding protein p88 is the product of the calnexin gene. Proc. Natl. Acad. Sci., 89: 8452-8456, 1992.
69. Tjoelker, L.W., Seyfried, C.E., Eddy, R.L., Jr., Byers, M.G., Shows, T.B., Calderon, J. Schreiber, R.B., and Gray, P.W. Human, mouse, and rat calnexin cDNA cloning: Identification of potential calcium binding motifs and gene localization to human chromosome 5. Biochemistry, 33: 3229-3236, 1994.
70. Schreiber, K.L., Bell, M.P., Huntoon, C.J., Rajagopalan, S., Benner, M.B., and McKean, D.J. Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum. Int. Immunol., 6: 101-111, 1994.
71. Honore, B., Rassmussen, H.H., Celis, A, Leffers, H., Madsen, P., and Celis, J.E. The molecular chaperones HSP28, GRP78, endoplasmin, and calnexin exhibit strikingly different levels in quiescent keratinocytes as compared to their proliferating normal and transformed counterparts; cDNA cloning and expression of calnexin. Electrophoresis, 15: 482-490, 1999.
72. Miki, T., Smith, C.L., Long, J.E., Eva, A., and Fleming, T.P. Oncogene ect2 is related to regulators of small FTP-binding proteins. Nature, 362: 462-465, 1993.
73. Adler, J.J., Winnicki, R.S., Gong, T.L., and Lomax, M.I. A gene up-regulated in the acoustically damaged chick basilar papilla encodes a novel WD40 repeat protein. Genomics, 56: 56-59, 1999.
74. Rachez, C., Suldan, Z., Bromleigh, V., Gamble, M., and Naar, A.M., Erdjument Bromage H., Tempst, P., and Freedman, L. P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature, 398: 824-827, 1999.
75. Ito, M., Yuan, C., Malik, S., Gu, W., Fondell, J.D., Yamamura, S., Fu, Z., Zhang, X., Qin, J., and Roeder, R.G. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell, 3: 361-370, 1999.